Network Pharmacology Combined With Metabolomics Reveals the Mechanism of Yangxuerongjin Pill Against Type 2 Diabetic Peripheral Neuropathy in Rats
Drug Design, Development and Therapy · 2025
DOI: 10.2147/dddt.s473146 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Ran Jin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Tongrentang Technology Development Co., Ltd. Pharmaceutical Factory, Beijing, 100079, People's Republic of China. Hauptthemen laut MEDLINE: Metabolomics, Network Pharmacology, Drugs, Chinese Herbal, Diabetic Neuropathies. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing Tongrentang Technology Development Co., Ltd. Pharmaceutical Factory, Beijing, 100079, People's Republic of China.
Zitieren
APA
Jin, R., Pei, H., Yue, F., Zhang, X., Zhang, Z., Xu, Y., & Li, J. (2025). Network Pharmacology Combined With Metabolomics Reveals the Mechanism of Yangxuerongjin Pill Against Type 2 Diabetic Peripheral Neuropathy in Rats. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s473146
Vancouver
Jin R, Pei H, Yue F, Zhang X, Zhang Z, Xu Y, et al. Network Pharmacology Combined With Metabolomics Reveals the Mechanism of Yangxuerongjin Pill Against Type 2 Diabetic Peripheral Neuropathy in Rats. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s473146
BibTeX
@article{Jin2025,
author = {Jin, Ran and Pei, Hailuan and Yue, Feng and Zhang, Xiaodi and Zhang, Zhicong and Xu, Yi and Li, Jinsheng},
title = {Network Pharmacology Combined With Metabolomics Reveals the Mechanism of Yangxuerongjin Pill Against Type 2 Diabetic Peripheral Neuropathy in Rats},
journal = {Drug Design, Development and Therapy},
year = {2025},
doi = {10.2147/dddt.s473146}
}
EUVIMED